Lupus Science and Medicine (Mar 2024)

P147 Is belimumab dose optimization possible in patients with systemic lupus erythematosus? Analysis of this therapeutic strategy in a large multicenter cohort of patients from Spanish rheumatology departments

  • Íñigo Rúa-Figueroa,
  • Jose Maria Pego-Reigosa,
  • Javier Narváez,
  • Ivette Casafont-Solé,
  • Eva Tomero,
  • Clara Moriano,
  • Elvira Díez Álvarez,
  • María Jesús García-Villanueva,
  • Consuelo Ramos Giráldez,
  • Sandra Garrote,
  • Maria Galindo Izquierdo,
  • Jaime Calvo Alen,
  • Beatriz Frade-Sosa,
  • Irene Altabás-González,
  • Andrea Hernández-Martín,
  • Paola Vidal-Montal,
  • Eleonora Penzo,
  • Marta de la Rubia Navarro,
  • José Andrés Román Ivorra,
  • Raul Menor Almagro,
  • Tarek Salman Montes,
  • Norman Jimenez,
  • Judit Font Urgelles,
  • Carlos Marras Fernández,
  • María Piqueras García,
  • Julia Martínez Barrio,
  • Marina Sánchez Lucas,
  • Josefina Cortés Hernández,
  • Myriam Gandía Martínez,
  • Carmen Trapero Pérez,
  • Alejandro Muñoz Jiménez,
  • Juan Ramón de Dios,
  • Jos A Gómez-Puerta

DOI
https://doi.org/10.1136/lupus-2024-el.201
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.